CTDNEP1 and nasopharyngeal carcinoma: The mice bearing Ctdnep1-cKO NPC tumors treated with both JQ1 and prexasertib had an increased lifespan compared to the mice treated only with JQ1, prexasertib, or vehicle (Fig. 7f).